Literature DB >> 2060539

Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracil.

J F Belliveau, M R Posner, G W Crabtree, A B Weitberg, M C Wiemann, F J Cummings, G P O'Leary, E Ingersoll, P Calabresi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2060539     DOI： 10.1007/bf00315150

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  15 in total

1.  Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma.

Authors:  C Dy; A Gil; S M Algarra; L A Aparicio; F Calvo; P Herranz
Journal:  Cancer Treat Rep       Date:  1986-04

2.  Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.

Authors:  M R Posner; J F Belliveau; A B Weitberg; K Sabbath; M C Wiemann; F J Cummings; P Calabresi
Journal:  Cancer Treat Rep       Date:  1987-10

3.  Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.

Authors:  F F Farris; F G King; R L Dedrick; C L Litterst
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

4.  cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.

Authors:  F M Schabel; M W Trader; W R Laster; T H Corbett; D P Griswold
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

5.  Curability of mouse L1210 leukemia by combination of 5-fluorouracil, cis-diamminedichloroplatinum(II), and low doses of gamma-rays.

Authors:  C Dionet; P Verrelle
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

6.  Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.

Authors:  F G King; R L Dedrick; F F Farris
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

7.  Pharmacological and biochemical interactions of N-(phosphonacetyl)-L-aspartate and 5-fluorouracil in beagles.

Authors:  A A Miller; E C Moore; R B Hurlbert; J A Benvenuto; T L Loo
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

8.  Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.

Authors:  G D Heggie; J P Sommadossi; D S Cross; W J Huster; R B Diasio
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

9.  Effects of combined treatments of cis-diamminedichloroplatinum(II), 5-fluorouracil, and X-rays on growth of human cancer nodules maintained in continuous organotypic culture.

Authors:  R Beaupain; C Dionet
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

10.  Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.

Authors:  J F Belliveau; M R Posner; L Ferrari; G W Crabtree; F J Cummings; M C Wiemann; G P O'Leary; H Griffin; M A Phaneuf; A O'Rourke
Journal:  Cancer Treat Rep       Date:  1986-10
View more
  2 in total

Review 1.  Recreational Nitrous Oxide Abuse: Prevalence, Neurotoxicity, and Treatment.

Authors:  Yuanyuan Xiang; Lei Li; Xiaotong Ma; Shan Li; Yuan Xue; Peng Yan; Meijie Chen; Junwei Wu
Journal:  Neurotox Res       Date:  2021-03-26       Impact factor: 3.911

Review 2.  Pharmacokinetic drug interactions with anticancer drugs.

Authors:  P M Loadman; M C Bibby
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.